
Canada’s National Advisory Committee on Immunization (NACI) is expected to recommend today a pause in the use of the AstraZeneca-Oxford COVID-19 vaccine on those under the age of 55 because of safety concerns, sources told CBC News.
The updated guidelines will be issued later today, according to sources who spoke on the condition of anonymity. The expected change in guidance comes following reports of rare blood clots in some immunized patients.
Canada is expected to receive 1.5 million doses of this product from the U.S. on Tuesday.
h/t Mauser98
